{
    "protocolSection": {
        "identificationModule": {
            "nctId": "NCT04175210",
            "orgStudyIdInfo": {
                "id": "19-07020533"
            },
            "organization": {
                "fullName": "Weill Medical College of Cornell University",
                "class": "OTHER"
            },
            "briefTitle": "Prospective Randomized Study of Accelerated Radiation Therapy (PRART)",
            "officialTitle": "Prospective Randomized Study of Accelerated Radiation Therapy (PRART) : A Non-Inferiority Trial to Compare Breast Cosmesis and Local Control After Concomitant Boost Breast Radiotherapy With Fifteen Fractions in Three Weeks (Arm 1, Standard) Versus Ten Fractions in Two Weeks (Arm 2, Experimental)",
            "acronym": "PRART",
            "therapeuticArea": [
                "Oncology and Hematology"
            ],
            "study": "prospective-randomized-study-of-accelerated-radiation-therapy-prart"
        },
        "statusModule": {
            "statusVerifiedDate": "2024-07",
            "overallStatus": "RECRUITING",
            "expandedAccessInfo": {
                "hasExpandedAccess": false
            },
            "startDateStruct": {
                "date": "2019-11-21",
                "type": "ACTUAL"
            },
            "primaryCompletionDateStruct": {
                "date": "2027-02-28",
                "type": "ESTIMATED"
            },
            "completionDateStruct": {
                "date": "2030-02-28",
                "type": "ESTIMATED"
            },
            "studyFirstSubmitDate": "2019-11-20",
            "studyFirstSubmitQcDate": "2019-11-21",
            "studyFirstPostDateStruct": {
                "date": "2019-11-22",
                "type": "ACTUAL"
            },
            "lastUpdateSubmitDate": "2024-07-24",
            "lastUpdatePostDateStruct": {
                "date": "2024-07-26",
                "type": "ACTUAL"
            }
        },
        "sponsorCollaboratorsModule": {
            "responsibleParty": {
                "type": "SPONSOR"
            },
            "leadSponsor": {
                "name": "Weill Medical College of Cornell University",
                "class": "OTHER"
            }
        },
        "oversightModule": {
            "oversightHasDmc": true,
            "isFdaRegulatedDrug": false,
            "isFdaRegulatedDevice": true
        },
        "descriptionModule": {
            "briefSummary": "Patients with Stage 0 ductal carcinoma in situ (Tis (DCIS), Stage T1-T2, lymph node negative(N0) breast cancers will be randomized to receive whole breast radiotherapy with a concomitant boost to the tumor bed over 15 fractions (Arm 1, standard) versus 10 fractions (Arm 2, experimental)."
        },
        "conditionsModule": {
            "conditions": [
                "Breast Cancer"
            ]
        },
        "designModule": {
            "studyType": "INTERVENTIONAL",
            "phases": [
                "PHASE3"
            ],
            "designInfo": {
                "allocation": "RANDOMIZED",
                "interventionModel": "PARALLEL",
                "primaryPurpose": "TREATMENT",
                "maskingInfo": {
                    "masking": "NONE"
                }
            },
            "enrollmentInfo": {
                "count": 400,
                "type": "ESTIMATED"
            }
        },
        "armsInterventionsModule": {
            "armGroups": [
                {
                    "label": "ARM 1-4050cGY and boost to tumor bed of 4800cGY in 15fractions",
                    "type": "EXPERIMENTAL",
                    "description": "Patients randomized to ARM 1 will receive whole breast radiotherapy of 4050cGY and a concomitant boost to the tumor bed of 4800cGY in 15 fractions",
                    "interventionNames": [
                        "Radiation: Radiation therapy - 3 weeks"
                    ]
                },
                {
                    "label": "ARM 2 - 3200cGY and boost to tumor bed of 4200cGY -10fractions",
                    "type": "EXPERIMENTAL",
                    "description": "Patients randomized to ARM 2 will receive whole breast radiotherapy of 3200cGY and a concomitant boost to the tumor bed of 4200cGY in 10 fractions.",
                    "interventionNames": [
                        "Radiation: Radiation therapy - 2 weeks"
                    ]
                }
            ],
            "interventions": [
                {
                    "type": "RADIATION",
                    "name": "Radiation therapy - 3 weeks",
                    "description": "Patients randomized to ARM 1 will receive whole breast radiotherapy of 4050cGY and a concomitant boost to the tumor bed of 4800cGY in 15 fractions",
                    "armGroupLabels": [
                        "ARM 1-4050cGY and boost to tumor bed of 4800cGY in 15fractions"
                    ]
                },
                {
                    "type": "RADIATION",
                    "name": "Radiation therapy - 2 weeks",
                    "description": "Patients randomized to ARM 2 will receive whole breast radiotherapy of 3200cGY and a concomitant boost to the tumor bed of 4200cGY in 10 fractions.",
                    "armGroupLabels": [
                        "ARM 2 - 3200cGY and boost to tumor bed of 4200cGY -10fractions"
                    ]
                }
            ]
        },
        "outcomesModule": {
            "primaryOutcomes": [
                {
                    "measure": "Proportions of patients with adverse cosmetic outcomes",
                    "description": "rate of grade 3 or higher changes in breast cosmesis on the 10 fraction arm compared to the rate on the 15 fraction arm will be measured.",
                    "timeFrame": "up to 2 years"
                }
            ],
            "secondaryOutcomes": [
                {
                    "measure": "Number of participants who demonstrate local control at 5 year follow up",
                    "description": "assess and compare local control at 5 years between the two arms.",
                    "timeFrame": "5 years"
                }
            ]
        },
        "eligibilityModule": {
            "eligibilityCriteria": "Inclusion Criteria:\n\n* Women status post segmental mastectomy\n* If unilateral, pT1-2 breast cancer excised with negative margins\n* If bilateral, pT1-2 breast cancer excised with negative margins AND/OR pTis excised with negative margins.\n* Clinically N0 or pN0 or sentinel node negative\n* Ductal carcinoma in situ DCIS with negative margins (no DCIS on inked margins).\n\nExclusion Criteria:\n\n* Previous radiation therapy to the ipsilateral breast.\n* 90 days from last surgery, unless s/p adjuvant chemotherapy\n* 60 days from last chemotherapy\n* Male breast cancer",
            "healthyVolunteers": false,
            "sex": "FEMALE",
            "minimumAge": "19 Years",
            "maximumAge": "90 Years",
            "stdAges": [
                "ADULT",
                "OLDER_ADULT"
            ]
        },
        "contactsLocationsModule": {
            "centralContacts": [
                {
                    "name": "Sharanya Chandrasekhar",
                    "role": "CONTACT",
                    "phone": "6469623110",
                    "email": "shc2043@med.cornell.edu"
                }
            ],
            "overallOfficials": [
                {
                    "name": "Silvia Formenti, M.D.",
                    "affiliation": "Weill Medical College of Cornell University",
                    "role": "PRINCIPAL_INVESTIGATOR"
                }
            ],
            "locations": [
                {
                    "facility": "New York Presbyterian Hospital at Lower Manhattan Cancer Center",
                    "status": "RECRUITING",
                    "city": "New York",
                    "state": "New York",
                    "zip": "10007",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Maahi Patel",
                            "role": "CONTACT",
                            "phone": "646-962-3118",
                            "email": "map4044@med.cornell.edu"
                        },
                        {
                            "name": "Sharanya Chandrasekhar",
                            "role": "CONTACT",
                            "phone": "646-962-3110",
                            "email": "shc2043@med.cornell.edu"
                        },
                        {
                            "name": "Silvia Formenti, M.D.",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 40.71427,
                        "lon": -74.00597
                    }
                },
                {
                    "facility": "Brooklyn Methodist Hospital - NewYork Presbyterian",
                    "status": "RECRUITING",
                    "city": "New York",
                    "state": "New York",
                    "zip": "11215",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Izael Nino",
                            "role": "CONTACT",
                            "email": "izn4001@med.cornell.edu"
                        },
                        {
                            "name": "Hani Ashamalla, M.D.",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 40.71427,
                        "lon": -74.00597
                    }
                },
                {
                    "facility": "New York Presbyterian Hospital - Queens",
                    "status": "RECRUITING",
                    "city": "New York",
                    "state": "New York",
                    "zip": "11355",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Krystalle Lyons",
                            "role": "CONTACT",
                            "phone": "718-670-1541",
                            "email": "krl4003@med.cornell.edu"
                        },
                        {
                            "name": "Akkamma Ravi, M.D.",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 40.71427,
                        "lon": -74.00597
                    }
                }
            ]
        },
        "ipdSharingStatementModule": {
            "ipdSharing": "NO"
        }
    },
    "derivedSection": {
        "miscInfoModule": {
            "versionHolder": "2024-07-30"
        },
        "conditionBrowseModule": {
            "browseLeaves": [
                {
                    "id": "M5220",
                    "name": "Breast Neoplasms",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "BC04",
                    "name": "Neoplasms"
                },
                {
                    "abbrev": "BC17",
                    "name": "Skin and Connective Tissue Diseases"
                },
                {
                    "abbrev": "All",
                    "name": "All Conditions"
                }
            ]
        }
    },
    "hasResults": false
}